These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25783198)

  • 41. Lung cancer screening now recommended for those at high risk.
    Harv Mens Health Watch; 2013 Nov; 18(4):8. PubMed ID: 27024792
    [No Abstract]   [Full Text] [Related]  

  • 42. Cancer Metrics on Subsequent Screening Rounds: Another Piece in the Complicated Puzzle.
    Hooley R; Philpotts L
    Radiology; 2024 Jul; 312(1):e241540. PubMed ID: 39078301
    [No Abstract]   [Full Text] [Related]  

  • 43. Lung Cancer Incidence and Mortality with Extended Follow-up during Screening.
    Grannis FW
    J Thorac Oncol; 2019 Oct; 14(10):1692-1694. PubMed ID: 31558228
    [No Abstract]   [Full Text] [Related]  

  • 44. Liquid biopsy: the time is even more right!
    Arnold L; Trivedi R
    MLO Med Lab Obs; 2016 Jan; 48(1):24. PubMed ID: 26887095
    [No Abstract]   [Full Text] [Related]  

  • 45. Response to "Commentary on: Lung cancer screening with MRI: results of the first screening round": Ngam Pei Ing et al.
    Meier-Schroers M; Schild HH; Thomas D
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1397-1398. PubMed ID: 29761373
    [No Abstract]   [Full Text] [Related]  

  • 46. "Commentary on: Lung cancer screening with MRI: results of the first screening round"-Michael Meier-Schroers et al.
    Ngam PI; Ling JZJ
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1395-1396. PubMed ID: 29748712
    [No Abstract]   [Full Text] [Related]  

  • 47. Surveillance and screening in lung cancer survivors.
    Bölükbas S; Baldes N; Eberlein M
    Eur J Cardiothorac Surg; 2020 Apr; 57(4):779-780. PubMed ID: 31808519
    [No Abstract]   [Full Text] [Related]  

  • 48. Educational Attainment and Loss to Follow-up in a Quebec Lung Cancer Screening Pilot Program.
    Mugutso E; Besson C; Hamed R; Noel F; Taylor J; Gonzalez A; Ezer N
    Ann Am Thorac Soc; 2023 Dec; 20(12):1819-1822. PubMed ID: 37748083
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cancer screening: yes or no? Aspects of a complex response].
    Haug U; Pigeot I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1481-1483. PubMed ID: 30430203
    [No Abstract]   [Full Text] [Related]  

  • 50. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.
    Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH
    Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
    Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Lammers JW; van Ooijen P; Nackaerts K; Weenink C; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H
    Thorax; 2017 Jan; 72(1):48-56. PubMed ID: 27364640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
    Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
    Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.
    Field JK; Duffy SW; Baldwin DR; Whynes DK; Devaraj A; Brain KE; Eisen T; Gosney J; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rassl DM; Rintoul RC; Screaton NJ; Wald NJ; Weller D; Williamson PR; Yadegarfar G; Hansell DM
    Thorax; 2016 Feb; 71(2):161-70. PubMed ID: 26645413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
    Paci E; Puliti D; Lopes Pegna A; Carrozzi L; Picozzi G; Falaschi F; Pistelli F; Aquilini F; Ocello C; Zappa M; Carozzi FM; Mascalchi M;
    Thorax; 2017 Sep; 72(9):825-831. PubMed ID: 28377492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indolent, Potentially Inconsequential Lung Cancers in the Pittsburgh Lung Screening Study.
    Thalanayar PM; Altintas N; Weissfeld JL; Fuhrman CR; Wilson DO
    Ann Am Thorac Soc; 2015 Aug; 12(8):1193-6. PubMed ID: 26107281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening for lung cancer: A systematic review and meta-analysis.
    Usman Ali M; Miller J; Peirson L; Fitzpatrick-Lewis D; Kenny M; Sherifali D; Raina P
    Prev Med; 2016 Aug; 89():301-314. PubMed ID: 27130532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ESR/ERS white paper on lung cancer screening.
    Kauczor HU; Bonomo L; Gaga M; Nackaerts K; Peled N; Prokop M; Remy-Jardin M; von Stackelberg O; Sculier JP; ;
    Eur Respir J; 2015 Jul; 46(1):28-39. PubMed ID: 25929956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
    Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
    Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen.
    Sverzellati N; Silva M; Calareso G; Galeone C; Marchianò A; Sestini S; Sozzi G; Pastorino U
    Eur Radiol; 2016 Nov; 26(11):3821-3829. PubMed ID: 26868497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-dose CT for lung cancer screening: opportunities and challenges.
    Shen H
    Front Med; 2018 Feb; 12(1):116-121. PubMed ID: 29218678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.